5 Best Biotech Stocks To Buy According To Hedge Funds

Page 1 of 5

In this article, we discuss 5 best biotech stocks to buy according to hedge funds. If you want to see more stocks in this selection, check out 10 Best Biotech Stocks To Buy According To Hedge Funds

5. United Therapeutics Corporation (NASDAQ:UTHR)

Number of Hedge Fund Holders: 47

United Therapeutics Corporation (NASDAQ:UTHR) is a biotechnology company engaged in the development and commercialization of medical products and therapies to address the unmet needs of patients with chronic and life-threatening diseases in the United States and internationally. On November 2, United Therapeutics Corporation (NASDAQ:UTHR) reported a Q3 GAAP EPS of $4.91 and a revenue of $516 million, outperforming Wall Street estimates by $1.10 and $22.54 million, respectively. 

On November 3, Wedbush analyst Andreas Argyrides raised the price target on United Therapeutics Corporation (NASDAQ:UTHR) to $305 from $250 following Q3 results. The analyst maintained an Outperform rating on the shares.

According to Insider Monkey’s third quarter database, 47 hedge funds were bullish on United Therapeutics Corporation (NASDAQ:UTHR), compared to 49 funds in the prior quarter. Kurt Von Emster’s VenBio Select Advisor is the leading stakeholder of the company, with approximately 3 million shares worth $612.75 million. 

Follow United Therapeutics Corp (NASDAQ:UTHR)

Page 1 of 5